Ixico
IXI · AIM · Health Care · mcap £17m · 7.8p
Financials · LTM to 31 Mar 26
Source: results 19 May 26 ↗
- Revenue
- £7.3m
- Operating profit
- −£3.2m
- Net income
- −£1.8m
- Free cash flow
- −£3.5m
- Net cash
- £1.7m
- Market cap
- £16.9m
- EV / EBIT
- –
- FCF yield
- −20.5%
- Price / book
- 1.6×
Latest half-year · H1 Mar 26 vs H1 Mar 25
results 19 May 26 ↗
- Revenue
- £3.9m +23%
- Operating profit
- −£1.6m prior −£929k
- Net income
- −£1.1m prior −£958k
- Cash from operations
- −£1.3m prior −£171k
Extracted automatically from the company's results announcements; check the source before relying on a figure. Not investment advice.
Latest report: H1 Mar 26 (six months to 31 Mar 26), published 19 May 26 · read the results ↗
£m unless stated · newest first · italic = calculated (LTM, H2 = FY − H1) · hover a value for its source
| LTM Mar 26 | FY Sep 25 | |
|---|---|---|
| Revenue | 7.3 | 6.5 |
| Gross profit | 3.7 | 3.2 |
| Operating profit | (3.2) | (2.6) |
| Amortisation | 0.3 | 0.2 |
| Share-based payments | 0.2 | 0.2 |
| Finance costs | (0.0) | (0.0) |
| Profit before tax | (3.1) | (2.4) |
| Tax | 1.3 | 0.8 |
| Net income (owners) | (1.8) | (1.7) |
| EPS basic | (2.0p) | (1.9p) |
| EPS diluted | (2.0p) | (1.9p) |
| H1 Mar 26 | vs H1 Mar 25 | H2 Sep 25 | H1 Mar 25 | |
|---|---|---|---|---|
| Revenue | 3.9 | +23% | 3.3 | 3.2 |
| Gross profit | 2.1 | +32% | 1.6 | 1.6 |
| EBITDA | (0.5) | n/m | – | (0.7) |
| Operating profit | (1.6) | n/m | (1.6) | (0.9) |
| Amortisation | 0.2 | +58% | 0.1 | 0.1 |
| Share-based payments | 0.1 | n/m | 0.1 | 0.1 |
| Finance costs | (0.0) | n/m | (0.0) | (0.0) |
| Profit before tax | (1.6) | n/m | (1.6) | (0.9) |
| Tax | 0.5 | n/m | 0.9 | (0.1) |
| Net income (owners) | (1.1) | n/m | (0.7) | (1.0) |
| EPS basic | (1.2p) | – | (0.7p) | (1.1p) |
| EPS diluted | (1.2p) | – | (0.7p) | (1.1p) |
| LTM Mar 26 | FY Sep 25 | |
|---|---|---|
| Cash from operations | (2.1) | (1.0) |
| Capex (PP&E) | (0.1) | (0.1) |
| Capex (intangibles) | (1.0) | (0.8) |
| Lease principal paid | (0.2) | (0.2) |
| Shares issued | (0.4) | 3.7 |
| Latest Mar 26 | FY Sep 25 | |
|---|---|---|
| Other intangibles | 7.0 | 7.2 |
| Property, plant & equipment | 0.6 | 0.2 |
| Trade receivables | 2.2 | 1.9 |
| Cash | 1.7 | 3.5 |
| Current assets | 5.1 | 6.2 |
| Total assets | 13.0 | 13.8 |
| Trade payables | 1.7 | 1.9 |
| Lease liabilities, current | 0.1 | 0.1 |
| Current liabilities | 1.8 | 2.1 |
| Lease liabilities, non-current | 0.4 | 0.0 |
| Total liabilities | 2.3 | 2.1 |
| Total equity | 10.7 | 11.7 |
| Order book | 18.1 | 13.8 |
| H1 Mar 26 | H2 Sep 25 | H1 Mar 25 | |
|---|---|---|---|
| Other intangibles | 7.0 | 7.2 | 6.5 |
| Property, plant & equipment | 0.6 | 0.2 | 0.2 |
| Trade receivables | 2.2 | 1.9 | 1.6 |
| Cash | 1.7 | 3.5 | 5.0 |
| Current assets | 5.1 | 6.2 | 7.3 |
| Total assets | 13.0 | 13.8 | 14.1 |
| Trade payables | 1.7 | 1.9 | 1.5 |
| Lease liabilities, current | 0.1 | 0.1 | 0.2 |
| Current liabilities | 1.8 | 2.1 | 1.7 |
| Lease liabilities, non-current | 0.4 | 0.0 | 0.1 |
| Total liabilities | 2.3 | 2.1 | 1.8 |
| Total equity | 10.7 | 11.7 | 12.3 |
| Order book | 18.1 | 13.8 | 13.1 |
Line items extracted automatically from each results announcement; when a later report restates a period, the later figure is shown. LTM and H2 are calculated from reported periods. Check the source before relying on a figure.
Company filings. Not investment advice.